Shukra Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 88.33 million compared to INR 69.34 million a year ago. Revenue was INR 115.94 million compared to INR 74.43 million a year ago. Net income was INR 1.04 million compared to INR 2.85 million a year ago. Basic earnings per share from continuing operations was INR 0.67 compared to INR 1.82 a year ago. Diluted earnings per share from continuing operations was INR 0.67 compared to INR 1.82 a year ago.